Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
Inhye E. Ahn Dana-Farber Cancer Institute Harvard Medical School Boston, MA, USA
Kenneth C. Anderson LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, USA
Julia Aronson Memorial Sloan Kettering Cancer Center New York, NY, USA
Francesco Bertoni Institute of Oncology Research Faculty of Biomedical Sciences USI, Bellinzona, Switzerland
Oncology Institute of Southern Switzerland Ente Ospedaliero Cantonale Bellinzona, Switzerland
Giada Bianchi Amyloidosis Program, Division of Hematology Department of Medicine, Brigham and Women's Hospital Harvard Medical School Boston, MA, USA
Noa Biran John Theurer Cancer Center at HMH and Hackensack Meridian School of Medicine Hackensack, NJ, USA
Alessandro Broccoli IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy Istituto di Ematologia "Seràgnoli" Dipartimento di Medicina Specialistica Diagnostica e Sperimentale Università degli Studi Bologna, Italy
Jennifer R. Brown Dana-Farber Cancer Institute Harvard Medical School Boston, MA, USA
Jan A. Burger Department of Leukemia The University of Texas MD Anderson Cancer Center Houston, TX, USA
Catherine C. Coombs University of North Carolina Chapel Hill,
NC, USA
Sandeep S. Dave Department of Medicine and Center for Genomic and Computational Biology Duke Cancer Institute, Duke University Durham, NC, USA
Matthew S. Davids Dana-Farber Cancer Institute Harvard Medical School Boston, MA, USA
Andrew Davies Southampton Cancer Research UK Centre Cancer Sciences Unit, Faculty of Medicine University of Southampton, Centre for Cancer Immunology Southampton General Hospital Southampton SO16 6YD, Hampshire, UK
Qing Deng Department of Lymphoma & Myeloma University of Texas MD Anderson Cancer Center Houston, TX, USA
Michael Dickinson Peter MacCallum Cancer Centre Melbourne,
Victoria, Australia Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne, Victoria, Australia
Sarah T. Diepstraten The Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia The Department of Medical Biology The University of Melbourne Melbourne, Victoria, Australia
Omar Elghawy University of Virginia Cancer Center University of Virginia School of Medicine Charlottesville, VA, USA Department of MedicineDivision of Hematology/Oncology University of Virginia School of Medicine Charlottesville, VA, USA
Toby Eyre University of Oxford Oxford, UK
David J. Feith University of Virginia Cancer Center University of Virginia School of Medicine Charlottesville, VA, USA Department of Medicine Division of Hematology/Oncology University of Virginia School of Medicine Charlottesville, VA, USA
Georgia Alice Galimberti Laboratory of Experimental Hematology Institute of Oncology Research Bellinzona, Switzerland
Philippe Gaulard Département de Pathologie Groupe Hospitalier Henri Mondor AP-HP, Créteil, France
Université Paris-Est INSERM U955, Créteil, France
Michael R. Green Department of Lymphoma & Myeloma University of Texas MD Anderson Cancer CenterHouston, TX, USA
Department of Genomic Medicine University of Texas MD Anderson Cancer Center Houston, TX, USA
Ashwin Gollerkeri Kymera Therapeutics Watertown, MA, USA
Jared Gollob Kymera Therapeutics Watertown, MA, USA
Andre Goy John Theurer Cancer Center at HMH and Hackensack Meridian School of Medicine Hackensack, NJ, USA
John G. Gribben Centre for Haemato-Oncology, Barts Cancer Institute Queen Mary University of London London, UK
Emily Gruber The Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
Sean Harrop Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
Matthew Ho Department of Internal Medicine Mayo Clinic,
Rochester, MN, USA
David C.S. Huang The Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia
The Department of Medical Biology The University of Melbourne Melbourne, Victoria, Australia
Prioty Islam Levine Cancer Center Raleigh, NC, USA
Yusuke Isshiki Division of Hematology and Oncology Joan and Sanford I Weill Department of Medicine Weill Cornell Medicine New York, NY, USA
Ricky Johnstone Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne, Victoria, Australia
Matko Kalac Precision Immunology Institute Tisch Cancer Center, Icahn School of Medicine at Mount Sinai New York, NY, USA
Lev M. Kats The Peter MacCallum Cancer Centre Melbourne, Victoria, Australia The Sir Peter MacCallum Department of Oncology University of Melbourne Parkville, Victoria, Australia
Gemma L. Kelly The Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia
John Kuruvilla Princess Margaret Cancer Centre University of Toronto Canada
Rob C. Laister Princess Margaret Cancer Centre University of Toronto Canada
Laurence de Leval Institute of Pathology Department of Laboratory Medicine and Pathology Lausanne University Hospital and Lausanne University Lausanne, Switzerland
Thomas E. Lew Department of Haematology The Royal Melbourne Hospital and Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
Blood Cells and Blood Cancer Division Walter and Eliza Hall Institute of Medical Research Parkville, Victoria, Australia
Alexander C. Lewis The Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
Jennifer K. Lue Memorial Sloan Kettering Cancer CenterLymphoma Service New York, NY, USA
Jemma Longley Southampton Cancer Research UK Centre, Cancer Sciences Unit, Faculty of Medicine University of Southampton, Centre for Cancer Immunology Southampton General Hospital Southampton SO16 6YD, Hampshire, UK
Thomas P. Loughran Jr University of Virginia Cancer Center University of Virginia School of Medicine Charlottesville, VA, USA
Department of Medicine, Division of Hematology/Oncology University of Virginia School of Medicine Charlottesville, VA, USA
Ralitsa R. Madsen University College London Cancer Institute Paul O'Gorman Building University College London London, UK
Nello Mainolfi Kymera Therapeutics Watertown, MA, USA
John Sanil Manavalan Division of Hematology-Oncology Department of Medicine, University of Virginia Comprehensive Cancer Center VA, USA
Farheen Manji Princess Margaret Cancer Centre University of Toronto Canada
John E. La Marca The Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia
Enrica Marchi Division of Hematology-Oncology Department of Medicine University of Virginia Comprehensive Cancer Center VA, USA
Anthony R. Mato Memorial Sloan Kettering Cancer Center New York, NY, USA
Joel McCay Centre for Haemato-Oncology, Barts Cancer Institute Queen Mary University of London London, UK
Ari Melnick Division of Hematology and Oncology Joan and Sanford I Weill Department of Medicine Weill Cornell Medicine New York, NY, USA
Anjali Mishra Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Department of Medical Oncology and Department of Cancer Biology, Sydney Kimmel Cancer Center Thomas Jefferson University Philadelphia, PA, USA
Owen A. O'Connor Department of Medicine, Division of Hematology and Medical Oncology T-Cell Malignancies Program University of Virginia Comprehensive Cancer Center Department of Microbiology Immunology and Cancer Biology University of Virginia Charlottesville, VA, USA
Robert Z. Orlowski Departments of Lymphoma & Myeloma, and Experimental Therapeutics The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Unit 429, Houston, TX 77030, USA
Ipsita Pal Division of Hematology-Oncology, Department of...
Dateiformat: ePUBKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „fließenden” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.
